Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T54940
(Former ID: TTDI01428)
|
|||||
Target Name |
Plasmodium Cysteine protease falcipain (Malaria CPF)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Literature-reported target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Malaria [ICD-11: 1F40-1F45] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Discontinued Drug(s) | [+] 1 Discontinued Drugs | + | ||||
1 | Pepstatin | Drug Info | Terminated | Malaria | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Inhibitor | [+] 2 Inhibitor drugs | + | ||||
1 | Pepstatin | Drug Info | [3] | |||
2 | Leupeptin | Drug Info | [3] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Falcipain inhibition as a promising antimalarial target. Curr Top Med Chem. 2012;12(5):408-44. | |||||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004280) | |||||
REF 3 | Novel molecular targets for antimalarial chemotherapy. Int J Antimicrob Agents. 2007 Jul;30(1):4-10. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.